Search

Your search keyword '"Garg, Amit X."' showing total 78 results

Search Constraints

Start Over You searched for: Author "Garg, Amit X." Remove constraint Author: "Garg, Amit X." Topic living donors Remove constraint Topic: living donors
78 results on '"Garg, Amit X."'

Search Results

1. Defining pre-emptive living kidney donor transplantation as a quality indicator.

2. Hypertension and Kidney Function After Living Kidney Donation.

4. Living Kidney Donors' Financial Expenses and Mental Health.

5. Evaluating multiple living kidney donor candidates simultaneously is more cost-effective than sequentially.

6. The kidney evaluation of living kidney donor candidates: US practices in 2017.

7. Metabolic, cardiovascular, and substance use evaluation of living kidney donor candidates: US practices in 2017.

8. A Propensity Score-weighted Comparison of Outcomes Between Living and Standard Criteria Deceased Donor Kidney Transplant Recipients.

9. Changes in kidney function follow living donor nephrectomy.

10. Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice.

11. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.

12. Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

13. Nonreimbursed Costs Incurred by Living Kidney Donors: A Case Study From Ontario, Canada.

14. Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

15. Direct and indirect costs incurred by Australian living kidney donors.

16. Potential implications of a more timely living kidney donor evaluation.

17. Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

18. Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.

19. Initiating Maintenance Dialysis Before Living Kidney Donor Transplantation When a Donor Candidate Evaluation Is Well Underway.

20. Identifying Outcomes that Are Important to Living Kidney Donors: A Nominal Group Technique Study.

21. APOL1 Genotype and Renal Function of Black Living Donors.

22. Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

23. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

24. Renal and cardiac assessment of living kidney donor candidates.

25. Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.

26. Risk of Nephrectomy in Previous Living Kidney Donors.

28. Acceptability of older adults as living kidney donors.

29. Gender differences in use of prescription narcotic medications among living kidney donors.

30. Race, Relationship and Renal Diagnoses After Living Kidney Donation.

31. Long-term medical risks to the living kidney donor.

32. Gout after living kidney donation: a matched cohort study.

33. Living kidney donation: outcomes, ethics, and uncertainty.

35. Gout after living kidney donation: correlations with demographic traits and renal complications.

36. End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?

37. Bone health in living kidney donors.

38. End-stage renal disease in living kidney donors.

40. Risk of serious gastrointestinal bleeding in living kidney donors.

41. Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors.

42. Understanding antihypertensive medication use after living kidney donation through linked national registry and pharmacy claims data.

43. Living kidney donor estimated glomerular filtration rate and recipient graft survival.

45. Acute dialysis risk in living kidney donors.

46. Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.

47. Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims.

49. Fracture risk in living kidney donors: a matched cohort study.

50. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.

Catalog

Books, media, physical & digital resources